Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Methotrexate | 10 | uM | 5 | 156.25 | 28.48 | 74.00 | 82.75 | 0.8943 | 0.8599 |
| SK-BR-3 | Palbociclib | 1 | uM | 5 | 156.25 | 28.48 | 67.00 | 82.75 | 0.8097 | 0.7436 |
| SK-BR-3 | Methotrexate | 0.31623 | uM | 5 | 156.25 | 28.48 | 62.00 | 82.75 | 0.7492 | 0.6579 |
| SK-BR-3 | Taxol | 0.0031623 | uM | 5 | 156.25 | 28.48 | 61.00 | 82.75 | 0.7372 | 0.6405 |
| SK-BR-3 | Methotrexate | 0.1 | uM | 5 | 156.25 | 28.48 | 83.00 | 82.75 | 1.0030 | 1.0039 |
| SK-BR-3 | Omipalisib | 0.31623 | uM | 5 | 156.25 | 28.48 | 105.00 | 82.75 | 1.2689 | 1.3347 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 111.00 | 82.75 | 1.3414 | 1.4206 | |
| SK-BR-3 | Palbociclib | 0.31623 | uM | 5 | 156.25 | 28.48 | 71.00 | 82.75 | 0.8580 | 0.8106 |
| SK-BR-3 | Omipalisib | 0.01 | uM | 5 | 156.25 | 28.48 | 92.00 | 82.75 | 1.1118 | 1.1426 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 92.00 | 82.75 | 1.1118 | 1.1426 | |
| SK-BR-3 | Omipalisib | 0.0033113 | uM | 5 | 156.25 | 28.48 | 68.00 | 82.75 | 0.8218 | 0.7605 |
| SK-BR-3 | Taxol | 0.1 | uM | 5 | 156.25 | 28.48 | 57.00 | 82.75 | 0.6888 | 0.5697 |
| SK-BR-3 | Taxol | 0.001 | uM | 5 | 156.25 | 28.48 | 93.00 | 82.75 | 1.1239 | 1.1577 |
| SK-BR-3 | Palbociclib | 3.1623 | uM | 5 | 156.25 | 28.48 | 54.00 | 82.75 | 0.6526 | 0.5155 |
| SK-BR-3 | Palbociclib | 0.031623 | uM | 5 | 156.25 | 28.48 | 56.00 | 82.75 | 0.6767 | 0.5518 |
| SK-BR-3 | Palbociclib | 19.9526 | uM | 5 | 156.25 | 28.48 | 82.00 | 82.75 | 0.9909 | 0.9882 |
| SK-BR-3 | Omipalisib | 10 | uM | 5 | 156.25 | 28.48 | 75.00 | 82.75 | 0.9063 | 0.8762 |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 84.00 | 82.75 | 1.0151 | 1.0196 | |
| SK-BR-3 | 0 | uM | 5 | 156.25 | 28.48 | 80.00 | 82.75 | 0.9668 | 0.9566 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 135.00 | 185.00 | 0.7297 | -0.0639 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 152.00 | 185.00 | 0.8216 | 0.2458 | |
| SK-BR-3 | Methotrexate | 0.0016596 | uM | 5 | 312.50 | 138.75 | 256.00 | 185.00 | 1.3838 | 3.3744 |
| SK-BR-3 | Methotrexate | 0.0033113 | uM | 5 | 312.50 | 138.75 | 175.00 | 185.00 | 0.9460 | 0.7494 |
| SK-BR-3 | Methotrexate | 3.1623 | uM | 5 | 312.50 | 138.75 | 155.00 | 185.00 | 0.8378 | 0.3058 |
| SK-BR-3 | Omipalisib | 0.031623 | uM | 5 | 312.50 | 138.75 | 162.00 | 185.00 | 0.8757 | 0.4525 |